ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

MARKET SNAPSHOT: U.S. Stocks Rally, Dow Tops 13,000

By Kate Gibson, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rallied on Friday, reclaiming weekly gains and pushing the Dow Jones Industrial Average to a nearly three-month high, as investors anticipated central-bank moves in Europe as well as by the U.S. Federal Reserve. Stocks hit session highs after Bloomberg News reported European Central Bank President Mario Draghi would hold talks with Bundesbank President Jens Weidmann in an attempt to remove the biggest obstacles to adopting new measures including bond purchases. "Between Draghi's comments and the GDP numbers today, we're bid up on prospects of monetary intervention," said Mark Luschini, chief investment strategist at Janney Montgomery Scott. After a 229-point rise, the Dow Jones Industrial Average (DJI) was lately up 179.25 points, or 1.4%, to 13,065.89, its first intraday rise above 13,000 since May 8. Merck & Co. Inc. (MRK) led the gains that included all but three of its 30 components. Merck shares rallied 3.8% after the pharmaceutical company's earnings topped forecasts. The S&P 500 index (SPX) added 23.03 points, or 1.7%, to 1,383.05, with health care and industrials the best performing of its 10 major industry sectors. Amgen Inc. (AMGN) gained 4.7% after the biotechnology company raised its 2012 outlook and reported second-quarter profit that exceeded analysts' estimates. The Nasdaq Composite (RIXF) gained 55.48 points, or 1.9%, to 2,948.71. Facebook Inc. (FB) shares slid 12% after the social-networking site offered little reassurance to investors concerned about its lofty valuation. For every stock declining, five gained on the New York Stock Exchange, where 491 million shares were exchanged as of 2:30 p.m. Eastern. Global equities gained after German Chancellor Angela Merkel and French President Francois Hollande said they were committed to keeping the euro area together. French newspaper Le Monde reported the European Central Bank was readying to purchase debt. The major stock indexes held gains after a gauge of consumer sentiment came in just above expectations, as did a separate report on U.S. economic growth in the second quarter. . Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Merck (MRK)
DateTimeHeadline
01/20/201716:01:00Merck Announces Settlement and License Agreement Resolving KEYTRUDA®...
01/20/201706:01:00Merck and Genea Open Centre of Excellence for Fertility
01/19/201701:30:00MSD for Mothers Commits $10 Million & Bus. Expertise to the Global...
01/18/201709:00:00Merck Foundation Grant Expands Project ECHO® in Vietnam and...
01/17/201716:47:01Statement of Changes in Beneficial Ownership (4)
01/12/201703:03:00Health Stocks Fall as Trump Slams Industry -- WSJ
01/10/201716:06:00Merck Receives FDA Acceptance of Supplemental Biologics License...
01/09/201708:00:00Incyte & Merck to Advance Clinical Development Program Investigating...
01/06/201708:00:00Merck to Participate at the 35th Annual J.P. Morgan Healthcare...
01/04/201715:05:00Pennsylvania Is Ordered to Provide Hepatitis C Drug to Inmate--Update
01/04/201711:32:00Pennsylvania Is Ordered to Provide Hepatitis C Drug to Inmate
01/03/201716:14:49Statement of Changes in Beneficial Ownership (4)
01/03/201716:14:24Statement of Changes in Beneficial Ownership (4)
01/03/201716:14:24Statement of Changes in Beneficial Ownership (4)
01/03/201716:14:24Statement of Changes in Beneficial Ownership (4)
01/03/201706:45:00Merck to Hold Fourth-Quarter and Full-Year 2016 Sales and Earnings...
12/28/201603:02:00Ahead of the Tape: Trump Gives 'Dogs of the Dow' Pause -- WSJ
12/27/201616:28:00Donald Trump Dogs Dow Strategy -- Ahead of the Tape
12/19/201617:52:00Biogen Names New CEO -- Update
12/19/201607:00:00KEYTRUDA® (pembrolizumab) Approved as First Anti-PD-1 Therapy...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US